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This paper will explore the relationships between and impacts of re-emerging infectious disease 
on international security and the role of international and domestic public health infrastructure of 
reducing the threat of biological terrorism.  What does the reemergence of polio say about the 
affect of a potential bioterrorist attack on the developed and the developing world?  Re-emerging 
infectious disease and the lack of public health infrastructure is a novel model for indirect 
deterrence and dis-motivation to commit acts of biological terrorism by foreign bioterrorists.  A 
bioterrorist attack, especially one with a contagious agent like smallpox or pneumonic plague, 
will impact the developing world substantially more than the U.S. or other nations with robust 
public health sectors.  One only has to look as far as polio’s reemergence in 2003 to see the very 
real repercussions, in terms of lives affected and cost, of a contagious virus on the developing 
world.  This paper intent is to examine polio’s reemergence in 2003, its subsequent spread, 
assess the implications for biological terrorism deterrence, and make recommendations with 
respect to international public health and security policy. 
 
At the beginning of 2003, the complete eradication of polio appeared to be within the grasp of 
the World Health Association and its many partners.  In 1998, the World Health Organization 
estimates there were over 365,000 new cases of polio; by early 2003, the rate of infection had 
declined to less than 1,000 new cases worldwide due to a vigilant vaccination effort.2  That trend 
was interrupted in August 2003, however, when unfounded allegations of contaminated vaccines 
that would lead to sterility, hinder testicular development and cause AIDs ran rampant in 
northern Nigeria’s most populous, predominantly Muslim State, Kano, which had adopted Sharia 
or Islamic law in 2000.  What started with the refusal of local clerics to allow vaccination led to 
the reestablishment or importation of the poliovirus to fourteen countries that were previously 
disease-free.   
 
Transport of the contagious virus was not limited to neighboring African states.  The poliovirus 
moved through Sudan to Ethiopia crossing the Red Sea to Lebanon, Saudi Arabia and Yemen.  
The latter was been particularly severely affected, witnessing more than five hundred new cases 
in the first half of 2005 alone.  The poliovirus spread as far as Indonesia, where it afflicted more 
than 150 people in a single year in two provinces, predominantly children.3  Prior to this 
outbreak, Indonesia had been polio free for nine years.  Genetic fingerprinting confirmed that the 
virus crippling children in Indonesia came from northern Nigeria through Sudan, most closely 
resembling an isolate recovered in Saudi Arabia in December 2004.  A pilgrim returning from 
Mecca or a returning foreign worker is suspected to have brought the virus to the island of Java, 
across an ocean and thousands of miles from its source.   
 
Countries that experience trends in poliovirus outbreaks appear to have a crucial commonality:  
social and political challenges impeding public health efforts that are the key to permanently 
eradicating polio.  Before 2003, polio had largely been confined to a handful of countries; 
Nigeria, India, Pakistan and Afghanistan accounted for 93% of the world’s cases.4  Unlike the 
rest of the world, these four countries have never succeeded in interrupting the transmission of 
wild type poliovirus.  Confirmed cases of poliomyelitis in 12 other countries, such as Niger and 
Nepal resulted from importing the virus from neighboring countries where the virus was 
endemic, especially Nigeria.  In places such as India, the center of the current circulation of the 
virus is in places where underserved people live, such as the minority Muslim population where 
70% of cases occur.5  Over the past few years, the effort to eradicate polio has been confronted 
with numerous challenges and outbreaks have resulted in twenty-five different countries, which 
were controlled only after more than two years of effort and at least $400 million in 
supplemental immunization activities.6   
Domestically, credible voices highlight unquestionable declines in our own public health 
infrastructure.  Beyond the passive or re-active defense component as part of Homeland Security, 
recognizing how strong and comprehensive our system is comparatively should be not be used as 
a rational to keep stagnant or decrease investment in our public health infrastructure.  Quite the 
contrary, the robust nature of our public health system is a strategic asset.  In thinking about 
public health as purely a responsive or passive part of homeland security, current national 
security policy is missing the more pro-active role that it could play.  As the presence of a 
ballistic missile defense system is supposed to be an existential deterrent itself, so is a strong 
public health system.   
 
The role of a robust public healthcare system, compared to those of developing nations, will be 
explored for its deterrence capacity applying an empirically driven case study method against 
predominant theories of deterrence7 and in comparison to other works considering the possibility 
of deterring bioterrorism.8  Whether one is focusing on the next influenza pandemic, 
bioterrorism, or the use of biological weapons by a rogue state, the role of a robust public health 
system for 21st Century deterrence remains to be explored.  There has not been a substantive 
consideration of our robust public health system as a strategic asset in a more active deterrence 
role.   
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